NON-IMMUNOGENIC RECOMBINANT STAPHYLOKINASE VERSUS ALTEPLASE FOR PATIENTS WITH MASSIVE PULMONARY EMBOLISM: A RANDOMIZED OPEN-LABEL, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY TRIAL, FORPE ArticleKirienko A.I., Leontyev S.G., Tereschenko S.N., Yavelov I.S., Shakhnovich R.M., Erlikh A.D., Talibov O.B., Yarovaya E.B., Semenov A.M., Semenov M.P., Ivanov S.V., Beregovykh V.V., Archakov A.I., Markin S.S., Klein H.V., Veremeychuk P.V., Tarkhanov R.V., Ponomarev E.A., Bobkov V.V., Rabinovich R.M. ...Journal of Thrombosis and Haemostasis. Том 23. 2025. С. 657-667
MANAGEMENT OF PREGNANCY AND DELIVERY IN CONGENITAL FIBRINOGEN DISORDERS: COMMUNICATION FROM THE ISTH SSC SUBCOMMITTEE ON FACTOR XIII AND FIBRINOGEN ArticleCasini Alessandro, Abdul Kadir Rezan, Abdelwahab Magy, Manco-Johnson M.J., Raut Sanj, Ross Cecil, De Moerloose Philippe, Santoro Cristina, Acharya SuchitraJournal of Thrombosis and Haemostasis. Том 22. 2024. С. 1516-1521